Nature Communications

SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis

2026-07-08

Full text

DOI https://doi.org/10.1038/s41467-026-73683-z